Literature DB >> 17763983

Interaction of dopamine system genes and cognitive functions in patients with schizophrenia and their relatives and in healthy subjects from the general population.

M V Alfimova1, V E Golimbet, I K Gritsenko, T V Lezheiko, L I Abramova, M A Strel'tsova, I V Khlopina, R Ebstein.   

Abstract

Linkage between the DRD4 and COMT genes and cognitive measures characterizing verbal memory, executive functions, and associative processes was studied in 150 patients with schizophrenia, 83 of their relatives, and 118 mentally healthy subjects without any family history of psychoses, with the aim of detecting the main effects of the polymorphic markers -809G/A and -521C/T (DRD4) and Val158Met (COMT) when present individually and together. The group of patients showed a main effect for polymorphism -521C/T on verbal fluency and an effect of the interaction of this polymorphism and the COMT gene on this cognitive trait. The highest level of verbal fluency was seen among carriers of the Val/Val+CC and Met/Met+TT genotypes. In the combined group of unaffected individuals, the interaction of the COMT and DRD4 -521C/TT genotypes had an effect on the standardness of speech associations due to a decrease in the standardness of associations in carriers of the Met/Met+CC genotype. Finally, both patients and unaffected individuals showed an effect for the interaction between the COMT and DRD4 -809G/A genotypes on working memory. Patients and healthy subjects showed similar features: the highest values were seen in subjects homozygous for the Val and G alleles, while the lowest values were seen in homozygotes for the Met and A alleles. These data provide evidence for a relationship between the DRD4 and COMT genes and different aspects of executive functions and the absence of such a relationship in relation to verbal memory.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17763983     DOI: 10.1007/s11055-007-0064-x

Source DB:  PubMed          Journal:  Neurosci Behav Physiol        ISSN: 0097-0549


  42 in total

1.  Regulation of working memory by dopamine D4 receptor in rats.

Authors:  Kehong Zhang; Christopher J Grady; Evangelia M Tsapakis; Susan L Andersen; Frank I Tarazi; Ross J Baldessarini
Journal:  Neuropsychopharmacology       Date:  2004-09       Impact factor: 7.853

Review 2.  Prefrontal neurons and the genetics of schizophrenia.

Authors:  D R Weinberger; M F Egan; A Bertolino; J H Callicott; V S Mattay; B K Lipska; K F Berman; T E Goldberg
Journal:  Biol Psychiatry       Date:  2001-12-01       Impact factor: 13.382

3.  Catechol-O-methyl transferase Val158Met gene polymorphism in schizophrenia: working memory, frontal lobe MRI morphology and frontal cerebral blood flow.

Authors:  B-C Ho; T H Wassink; D S O'Leary; V C Sheffield; N C Andreasen
Journal:  Mol Psychiatry       Date:  2005-03       Impact factor: 15.992

4.  A genetic polymorphism in the promoter region of DRD4 associated with expression and schizophrenia.

Authors:  Y Okuyama; H Ishiguro; M Toru; T Arinami
Journal:  Biochem Biophys Res Commun       Date:  1999-05-10       Impact factor: 3.575

Review 5.  Should schizophrenia be treated as a neurocognitive disorder?

Authors:  M F Green; K H Nuechterlein
Journal:  Schizophr Bull       Date:  1999       Impact factor: 9.306

6.  Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia.

Authors:  M F Egan; T E Goldberg; B S Kolachana; J H Callicott; C M Mazzanti; R E Straub; D Goldman; D R Weinberger
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-29       Impact factor: 11.205

7.  Catechol O-methyltransferase val158-met genotype and individual variation in the brain response to amphetamine.

Authors:  Venkata S Mattay; Terry E Goldberg; Francesco Fera; Ahmad R Hariri; Alessandro Tessitore; Michael F Egan; Bhaskar Kolachana; Joseph H Callicott; Daniel R Weinberger
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-25       Impact factor: 11.205

8.  A functional genetic variation of the 5-HT2a receptor affects human memory.

Authors:  Dominique J-F de Quervain; Katharina Henke; Amanda Aerni; Daniel Coluccia; M Axel Wollmer; Christoph Hock; Roger M Nitsch; Andreas Papassotiropoulos
Journal:  Nat Neurosci       Date:  2003-10-19       Impact factor: 24.884

9.  [Influence of long-term quetiapine (Seroquel) and haloperidol therapy on cognitive deficit in patients with paranoid schizophrenia].

Authors:  S N Mosolov; S O Kabanov
Journal:  Zh Nevrol Psikhiatr Im S S Korsakova       Date:  2004

Review 10.  The catechol-O-methyltransferase polymorphism: relations to the tonic-phasic dopamine hypothesis and neuropsychiatric phenotypes.

Authors:  Robert M Bilder; Jan Volavka; Herbert M Lachman; Anthony A Grace
Journal:  Neuropsychopharmacology       Date:  2004-11       Impact factor: 7.853

View more
  5 in total

1.  Relationship of striatal dopamine synthesis capacity to age and cognition.

Authors:  Meredith N Braskie; Claire E Wilcox; Susan M Landau; James P O'Neil; Suzanne L Baker; Cindee M Madison; Jennifer T Kluth; William J Jagust
Journal:  J Neurosci       Date:  2008-12-24       Impact factor: 6.167

2.  Candidate endophenotypes for genetic studies of suicidal behavior.

Authors:  J John Mann; Victoria A Arango; Shelli Avenevoli; David A Brent; Frances A Champagne; Paula Clayton; Dianne Currier; Donald M Dougherty; Fatemah Haghighi; Susan E Hodge; Joel Kleinman; Thomas Lehner; Francis McMahon; Eve K Mościcki; Maria A Oquendo; Ganshayam N Pandey; Jane Pearson; Barbara Stanley; Joseph Terwilliger; Amy Wenzel
Journal:  Biol Psychiatry       Date:  2009-02-07       Impact factor: 13.382

3.  Dopaminergic gene polymorphisms and cognitive function in a north Indian schizophrenia cohort.

Authors:  Prachi Kukshal; Venkat Chowdari Kodavali; Vibhuti Srivastava; Joel Wood; Lora McClain; Triptish Bhatia; A M Bhagwat; Smita Neelkanth Deshpande; Vishwajit Laxmikant Nimgaonkar; B K Thelma
Journal:  J Psychiatr Res       Date:  2013-08-08       Impact factor: 4.791

4.  Positive effects of methylphenidate on hyperactivity are moderated by monoaminergic gene variants in children with autism spectrum disorders.

Authors:  J T McCracken; K K Badashova; D J Posey; M G Aman; L Scahill; E Tierney; L E Arnold; B Vitiello; F Whelan; S Z Chuang; M Davies; B Shah; C J McDougle; E L Nurmi
Journal:  Pharmacogenomics J       Date:  2013-07-16       Impact factor: 3.550

5.  Tolcapone-Enhanced Neurocognition in Healthy Adults: Neural Basis and Predictors.

Authors:  Savita G Bhakta; Gregory A Light; Jo A Talledo; Bryan Balvaneda; Erica Hughes; Alexis Alvarez; Brinda K Rana; Jared W Young; Neal R Swerdlow
Journal:  Int J Neuropsychopharmacol       Date:  2017-12-01       Impact factor: 5.678

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.